 |
|
| Type | Public (Euronext: OME) |
|---|---|
| Founded | 1987 |
| Headquarters | Nazareth, Belgium |
| Key people | Marc Coucke (CEO), Jan Cassiman (COO), Lucas Laureys (Chairman of the board) |
| Industry | Pharmaceuticals |
| Products | Prescription-free medicines and healthcare products, products and services for medical professionals |
| Revenue | €811.3 million (2008)[1] |
| Operating income | ▲ €98.6 million (2008)[1] |
| Profit | ▲ €54.4 million (2008)[1] |
| Employees | 2,040 (2008)[1] |
| Website | www.omega-pharma.be |
Omega Pharma is a Belgian Pharmaceutical company, founded in 1987 by Marc Coucke (born 1965) and Yvan Vindevogel, both former Pharmacy students at the Ghent University.
The company is quoted at Euronext Brussels and makes part of the BEL20 index.
Arseus
At the occasion of the annual shareholders meeting of June 6th 2006; Omega Pharma announced the name under which its Professional Health division will henceforward operate: Arseus. Simultaneously, the management team of Arseus was presented. The legal structure of the entities in this division has been largely prepared in the mean time, so that the project to make Arseus an autonomous company is on schedule. In the framework of this project, it is expected that Arseus, as an autonomous company, will become stock-listed by 2008.
References
- ^ a b c d "Annual Report 2008". Omega Pharma. http://www.omega-pharma.be/EN/pdf/jaarverslag_en_def.pdf. Retrieved 2009-05-25.
External links
|
|||||
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
